Sulforaphane

Cat. No. NATM-2505-CXX-189

Package 5 mg/10 mg/25 mg/50 mg/100 mg/200 mg/500 mg

Description

Sulforaphane, an orally active Keap1/Nrf2/ARE pathway inducer, promotes tumor-suppressing protein transcription and inhibits HDAC activity. Activating the Keap1/Nrf2/ARE pathway and inducing HO-1, it protects the heart. Sulforaphane also suppresses high glucose-induced pancreatic cancer via AMPK signaling. It possesses anticancer and anti-inflammatory properties.

Product Details

Purity	98.87%
Formula	C6H11NOS2
Molecular Weight	177.29
SMILES	O=S(CCCCN=C=S)C
Appearance	Liquid
Color	Less to light yellow
Biological Target	HDAC; Keap1-Nrf2; Apoptosis; Bcl-2 Family; Caspase; Reactive Oxygen Species
Target	HDAC; Bax; Caspase-3
Initial Source	Plants; other families
Solubility	DMSO: 62.5 mg/mL (352.53 mM)
Shipping Conditions	Room Temperature
Storage Information	Powder: -80°C, 2 years; -20°C, 1 years. In solvent: -80°C, 6 months; -20°C, 1 month